Dr. Aria F. Olumi</h1> <article> <h1>Dr. Aria F. Olumi</h1> <p>julie — Tuesday, March 5, 2024, 3:35pm</p> <p>Dr. Aria F. Olumi is an urologist in Boston, Massachusetts and is affiliated with <a href="https://health.usnews.com/best-hospitals/area/ma/beth-israel-deaconess-medical-center-6140013">Beth Israel Deaconess Medical Center</a>. He received his medical degree from University of Southern California School of Medicine and has been in practice for more than 20 years. Dr. Aria F. Olumi has expertise in treating prostate cancer, among other conditions . His clinical practice is focused on caring for patients with urologic tumors through open and minimally invasive, robotic, laparoscopic, and endoscopic approaches. In addition, Dr. Olumi serves as Chair of the Research Council for the American Urological Association, the largest international urologic society with a membership of over 22,000. In this role, Olumi has been responsible for oversight of multiple committees that develop plans for public research advocacy at the national level with the NIH and the Department of Defense, national conference planning, and enhancing research and educational opportunities for the urologic community. He also has been an associate editor of the <em>Journal of Urology</em>.</p> </article> <article> <h1>Dr. Zongwei Wang</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 11:52am</p> <p>Dr. Wang is the Assistant Professor in the Department of Urological Surgery at Beth Israel Deaconess Medical Center and leads a joint laboratory with department chair Dr. Aria F. Olumi. The Olumi/Wang laboratory investigates SRD5A2-related non-androgenic pathways that contribute to the maintenance of prostatic homeostasis.</p> </article> <article> <h1>Dr. Boqing Gu</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 3:50pm</p> <p>Dr. Gu earned his PhD in Pharmacology from the Indiana University School of Medicine in 2024. In August 2024, he joined the Olumi/Wang Lab in the Division of Urological Surgery at BIDMC as a postdoctoral research fellow. His current research focuses on the molecular mechanisms of SRD5A2-regulated signaling pathways in the prostate.</p> </article> <article> <h1>Dr. Danyu Chen</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 3:56pm</p> <p>Dr. Chen's research is dedicated to translating basic scientific discoveries into novel cancer therapies. She began this work during her Ph.D. at The Chinese University of Hong Kong under the supervision of Prof. Jun Yu and Prof. Dennis Chi Chun Wong. There, she leveraged cancer organoid models to investigate the epitranscriptome, laying the groundwork for innovative immunotherapy and drug screening approaches. To directly impact patient care, she pursued postdoctoral training at Harvard Medical School's Beth Israel Deaconess Medical Center with Dr. Aria Olumi and Prof. Wang Zongwei. Her research focused on repurposing FDA-approved drugs for prostate cancer and benign prostatic hyperplasia (BPH), expanding her expertise in drug discovery utilizing human organoid models.</p> </article> <article> <h1>Dr. Xingbo Long</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 3:58pm</p> <p>Dr. Long is a medical doctor and attending urologist at the Sun Yat-sen University Cancer Center. His clinical and research work focuses on the diagnosis and treatment of prostate diseases.</p> </article> <article> <h1>Yulia Mulugeta</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 4:00pm</p> </article> <article> <h1>Dr. Jamil Almohtasib</h1> <p>bgu@bidmc.harvard.edu — Tuesday, October 7, 2025, 4:02pm</p> <p>Dr. Almohtasib earned his MD degree from the University of Jordan in 2024. He completed a one-year research fellowship in the Department of Urology at the Mayo Clinic before joining the Urologic Oncology Research Fellowship Program at BIDMC. His research focuses on improving diagnostic and treatment strategies in bladder and prostate cancer through advanced imaging and outcomes-based studies, with additional interests in Men's Health research.</p> <p>His long-term goal is to pursue a career as a physician–scientist in urology, dedicated to improving treatment outcomes and patient care. Outside of research, he enjoys playing sports, hiking, traveling, and discovering new places.</p> </article> <article> <h1>Jie Ming</h1> <p>bgu@bidmc.harvard.edu — Wednesday, October 8, 2025, 9:54am</p> <p>Jie is the PhD candidate from Capital Medical University, Beijing, China. In Olumi/Wang Lab Jie is mainly involved in projects investigating the role of estrogen in the mechanisms of benign prostatic hyperplasia, as well as studying FGFR3 gene variations in the progression of bladder cancer. Jie has a strong interest in computer science and bioinformatics, including single-cell sequencing, spatial transcriptomics, bulk sequencing, and machine learning approaches. Outside of research, He enjoys singing, playing badminton, and computer gaming.</p> </article> <article> <h1>Lucia Elting</h1> <p>bgu@bidmc.harvard.edu — Wednesday, October 8, 2025, 10:07am</p> </article> <article> <h1>Dr. Zahra Ansari</h1> <p>bgu@bidmc.harvard.edu — Wednesday, October 8, 2025, 11:10am</p> <p>Dr. Ansari earned her Doctor of Veterinary Medicine degree from the University of Tehran, Iran, where she first developed an interest in translational research. She later moved to the U.S. to pursue her passion for biomedical science and completed a postdoctoral fellowship at Columbia University, where she worked on skin regeneration and gene therapy. Outside of the lab, Dr. Ansari enjoys yoga, running, reading, and cooking.</p> </article> </main></body></html>